Schonfeld Strategic Advisors LLC Eli Lilly & CO Transaction History

Schonfeld Strategic Advisors LLC

$15 Billion
Q1 2025

A detailed history of Schonfeld Strategic Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 24,547 shares of LLY stock, worth $17.8 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

24,547

Previous 21,019 16.78%

Holding current value

$17.8 Million

Previous $16.2 Million 24.94%

% of portfolio

0.13%

Previous 0.11%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$725.72 - $929.72 $2.56 Million - $3.28 Million	3,528 Added 16.78%	24,547 $20.3 Million
Q4 2024 Feb 14, 2025	BUY	$727.2 - $932.06 $4.03 Million - $5.16 Million	5,539 Added 35.78%	21,019 $16.2 Million
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $6.18 Million - $7.69 Million	8,010 Added 107.23%	15,480 $13.7 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $2.6 Million - $3.27 Million	-3,593 Reduced 32.48%	7,470 $6.76 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $5.81 Million - $7.78 Million	9,818 Added 788.59%	11,063 $8.61 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $39.1 Million - $46.1 Million	-74,474 Reduced 98.36%	1,245 $725,000
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $21.6 Million - $29.7 Million	49,593 Added 189.82%	75,719 $40.7 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $9.06 Million - $12.1 Million	25,826 Added 8608.67%	26,126 $12.3 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $1.61 Million - $1.89 Million	-5,183 Reduced 94.53%	300 $103,000
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $380,393 - $443,234	1,183 Added 27.51%	5,483 $2.01 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $5.43 Million - $6.19 Million	-18,321 Reduced 80.99%	4,300 $1.39 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $6.31 Million - $7.4 Million	22,621 New	22,621 $7.33 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $2.21 Million - $2.75 Million	-9,418 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $483,877 - $600,494	-2,152 Reduced 18.6%	9,418 $2.6 Million
Q3 2021 Nov 16, 2021	SELL	$221.6 - $272.71 $12.6 Million - $15.5 Million	-56,757 Reduced 83.07%	11,570 $2.67 Million
Q2 2021 Nov 16, 2021	SELL	$180.55 - $233.54 $1.5 Million - $1.94 Million	-8,319 Reduced 10.85%	68,327 $15.7 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $13.8 Million - $17.9 Million	76,646 New	76,646 $17.6 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $3.89 Million - $5.04 Million	-23,700 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $3.57 Million - $4.72 Million	-27,329 Reduced 53.56%	23,700 $4 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $6.68 Million - $7.73 Million	45,709 Added 859.19%	51,029 $8,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $725,754 - $873,437	5,320 New	5,320 $873,000
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $587,392 - $727,024	-4,934 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $852,152 - $1.06 Million	-7,970 Reduced 61.76%	4,934 $648,000
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $641,167 - $697,424	6,004 Added 87.01%	12,904 $1.44 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $838,791 - $979,081	-7,571 Reduced 52.32%	6,900 $764,000
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $1.61 Million - $1.9 Million	14,471 New	14,471 $1.88 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $3.26 Million - $3.5 Million	-39,773 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $3.07 Million - $3.4 Million	39,773	39,773 $3.4 Million

Others Institutions Holding LLY

# of Institutions

4,384

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $689B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Eli Lilly & CO Transaction History